Personalized therapeutic approaches for asthma
Journal of Allergy and Clinical Immunology · 2025-09 · 156 (3) · 503-522
DOI: 10.1016/j.jaci.2025.03.025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-09. Verfasst von Ioana Agache und 13 weiteren Autor:innen. Beteiligte Einrichtung: Transylvania University, Brasov, Romania. Electronic address: ibrumaru@unitbv.ro. Hauptthemen laut MEDLINE: Asthma, Precision Medicine. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 255 Literaturangaben.
Abstract (Originalsprache)
Differences in host susceptibility and environmental exposures result in significant heterogeneity in asthma clinical expression, natural evolution, and response to treatment. These differences are influenced by many factors including genomics, epigenomics, transcriptomics, proteomics, and metabolomics, many of which are modified by environmental and allergic exposures. The complex and multiple characteristics that interact in asthma development and progression pose significant challenges for personalized management. This review aims to guide the clinician in its management decisions by reviewing each of the components important in developing this therapeutic paradigm and by providing several integrated goals for precision or personalized medicine for asthma. Biologic characteristics of asthma in relation to the genomics, exposome, and hypersensitivity reactions (allergic responsiveness) resulting in asthma diathesis are discussed. Further insights including the use of targeted biologics and allergen immunotherapy are provided, while discussing the importance of targeting the epithelium, mucus production, airway smooth muscle, and small airways. We examine the value of multivariate cluster analyses as a new paradigm that can inform treatment decisions and the potential of adaptive trial design to evaluate known and novel predictive biomarkers and characterize disease heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Transylvania University, Brasov, Romania. Electronic address: ibrumaru@unitbv.ro.
- Department of Respiratory Cell and Molecular Biology, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
- Respiratory Medicine, University of Ferrara, Ferrara, Italy.
- Experimental Medicine Studies, National Heart and Lung Institute, Imperial College, London, and the Royal Brompton & Harefield Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
- Allergy Research Group, Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BIONAND, RETICS Asma, Reacciones Adversas y Alergicas (ARADyAL), and RICORS "Enfermedades Inflamatorias," Malaga, Spain; Allergy…
- National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Zitieren
APA
Agache, I., Adcock, I. M., Baraldi, F., Chung, K. F., Eguiluz-Gracia, I., Johnston, S. L., Jutel, M., Nair, P., Papi, A., Porsbjerg, C., Usmani, O. S., Meyers, D. A., Zemelka-Wiacek, M., & Bleecker, E. R. (2025). Personalized therapeutic approaches for asthma. Journal of Allergy and Clinical Immunology, 156(3), 503-522. https://doi.org/10.1016/j.jaci.2025.03.025
Vancouver
Agache I, Adcock IM, Baraldi F, Chung KF, Eguiluz-Gracia I, Johnston SL, et al. Personalized therapeutic approaches for asthma. Journal of Allergy and Clinical Immunology. 2025;156(3):503-522. doi:10.1016/j.jaci.2025.03.025
BibTeX
@article{Agache2025,
author = {Agache, Ioana and Adcock, Ian M and Baraldi, Federico and Chung, Kian Fan and Eguiluz-Gracia, Ibon and Johnston, Sebastian L and Jutel, Marek and Nair, Parameswaran and Papi, Alberto and Porsbjerg, Celeste and Usmani, Omar S and Meyers, Deborah A and Zemelka-Wiacek, Magdalena and Bleecker, Eugene R},
title = {Personalized therapeutic approaches for asthma},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {156},
number = {3},
pages = {503--522},
doi = {10.1016/j.jaci.2025.03.025}
}
EUVIMED